MedTrace Logo

Atorvastatin in the TREATment of Intracranial Unruptured VertebroBasilar Dissecting Aneurysms

NCT04943783 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-04-06

No results posted yet for this study

Summary

This study was designed to whether there is a measurable reduction in inflammation in walls of unruptured vertebrobasilar dissecting aneurysms with atorvastatin.

Conditions

  • Dissecting Aneurysm of Cerebral Artery
  • Intramural Hematomas
  • Inflammation Vascular

Interventions

DRUG

Atorvastatin 20mg

One with the intervention (Atorvastatin, 20mg OD), 20 patients for this arm.

Sponsors & Collaborators

  • Beijing Neurosurgical Institute

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2022-01-01
Completion
2022-07-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04943783 on ClinicalTrials.gov